veonet is the leading European ophthalmology group

Our History

veonet's members are leading providers of ophthalmic care in their regions

2022 – Expansion of network in Spain with Miranza

Expansion of network in Spain with Miranza

2021 – Launch of veonet brand and opening of veonet holding office

2019 – Expansion of network in the Netherlands with eyescan

Expansion of network in the Netherlands with eyescan

2020 – Expansion of network in UK with SpaMedica

Expansion of network in UK with SpaMedica
Our Mission

Our mission is to ensure every patient enjoys lifelong healthy vision, enhancing their overall health and wellbeing.

 Excellence
Excellence

We are dedicated to delivering the best clinical outcomes for our patients. Our professionals have long-lasting expertise leveraging the most innovative technology and treatment methods.

 Care
Care

We are dedicated to delivering exceptional experiences for our patients showing empathy and focusing on their unique needs.

 Integrity
Integrity

We strive for the highest standards and continuous development while ensuring responsibility and sustainability in all our actions.

 Teamwork
Teamwork

We are committed to building a trusted, inclusive and agile culture that fosters empowerment, collaboration and supports our local and national teams.

>280

clinics in 5 countries

>2.7

million ophthalmological procedures

Our Medical Specialties

veonet covers the entire range of ophthalmological procedures

Cataracts

Cataracts are globally the primary cause of age-related preventable blindness. Its treatment requires surgery, with advanced phacoemulsification and intraocular lens implantation restoring clarity. While cataract surgery is generally safe, patients with co-existing conditions can face increased risks. Our specialized surgeons identify and manage these complexities, ensuring optimal outcomes and significantly enhancing patient vision and quality of life, reducing the associated healthcare burden.

Portfolio Image
Retina

Retinal conditions, both medical and surgical, are treated with advanced techniques to preserve and restore vision. Common diseases like age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusions are treated using cutting-edge imaging and intravitreal injections, while surgical procedures such as pars plana vitrectomy address other complex issues like retinal detachments, macular holes or epiretinal membranes. These treatments aim to preserve vision, considerably impacting patient independence and quality of life.

Portfolio Image
Glaucoma

Glaucoma, commonly known as the silent thief of vision, is prevalent worldwide and predicted to increase to more than 100 million people in 2040. Employing advanced diagnostics and minimally invasive surgeries and treatments, vision loss can be prevented, safeguarding patients’ quality of life

Portfolio Image
Refractive surgery

During adulthood, vision correction through LASIK, PRK or KLEx reduces the need for glasses. With the onset of presbyopia, causing near-vision loss, multifocal lens implants can restore focus reducing dependency on reading glasses and enhancing patients’ daily life. These premium surgical treatments provide lasting results, boosting patient confidence and lifestyle quality.

Portfolio Image
Cornea

The cornea is the outtermost transparent layer of the eye and conditions affecting it such us keratoconus, keratitis, infections or corneal dystrophies can threaten sight. The latest advancements in imaging techniques and surgical treatments of corneal disorders such as cross-linking and others aim to slow disease progression and/or restore sight, improving patient outcomes.

Portfolio Image
Oculoplastics

Addressing eyelid and tear duct disorders enhances both function and appearance. Surgical interventions such as blepharoplasty can improve patient comfort, aesthetics, confidence, and overall quality of life

Portfolio Image
Paediatric ophthalmology

Childhood eye conditions such as strabismus, amblyopia, congenital cataracts or retinopathy of prematurity can impact development if untreated. Early intervention with advanced therapies ensures proper vision development, benefiting long-term health and learning.

Portfolio Image
Management Team

Who we are

Sebastian James
Sebastian James

Group CEO

Nick Maddock
Nick Maddock

Group CFO

Marcos Bueso
Marcos Bueso

Group COO

Richard Woodward
Richard Woodward

CEO SpaMedica

Carla Naumann
Carla Naumann

CEO OSG

Christoph Gassner
Christoph Gassner

CEO VISTA

Ramon Berra
Ramon Berra

CEO Miranza

Jannes Janssens
Jannes Janssens

CEO eyescan

Jose Merle
Jose Merle

Group Head of M&A